MARSHALL & POPP, LLC

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Biopharmaceutical manufacturer.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Massachusetts · House · Senate · $40,000.00 income · posted Apr 21, 2025

Bills named in this filing 2

Lobbying activity 1

Medicare/Medicaid

Issues related to pain management, including S.475/H.R. 1227 - Alternatives to PAIN Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.